In conclusion, using an in vivo approach, our study demonstrated that the HIV transactivator protein Tat contributes to HIV-associated endothelial dysfunction via promoting adipose mass loss, and leptin level reduction leading to an upregulated expression of Nox1 and NoxA1 (Figure 5). The gene discussed is TAT; the disease is endothelial dysfunction.